German Energy Services Stock News

As European markets navigate a landscape marked by volatility and concerns over AI disruption, the pan-European STOXX Europe 600 Index recently reached a new high before settling with modest gains. Amidst these fluctuations, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Aroundtown (XTRA:AT1) has just reshaped part of its funding mix by completing offers to repurchase subordinated notes while issuing new hybrid instruments, a move focused on refinancing existing liabilities and keeping its hybrid capital portfolio broadly intact. See our latest analysis for Aroundtown. Aroundtown’s recent hybrid refinancing comes after a mixed share price pattern, with the latest €2.79 level sitting above year to date share price returns of 6.65% but alongside a 5 year total...

INDUS Holding AG ( ETR:INH ), might not be a large cap stock, but it led the XTRA gainers with a relatively large price...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Earlier this week, Mercedes-Benz Group AG reported its weakest earnings since the pandemic, with annual operating profit almost halving after around US$1.20 billion in tariff costs, a sharp sales drop in China, and restructuring charges, while also guiding for 2026 revenue to remain around prior-year levels but group EBIT to be significantly higher and proposing a reduced €3.50 per-share dividend for 2025 (2024: €4.30). At the same time, the company is pushing its largest-ever product and...

Restructuring pivot puts Continental (XTRA:CON) in focus Continental’s decision to spin off its Automotive division into Aumovio SE and pursue a ContiTech divestment, thereby turning itself into a focused tire business, has quickly drawn a constructive market response. See our latest analysis for Continental. That pivot has arrived alongside building momentum in the shares, with a 30-day share price return of 11.71% and a 90-day share price return of 16.87%, while the 1-year total shareholder...

In recent months, Allianz has been refining its portfolio and risk profile through new joint ventures and partnerships in reinsurance and technology, set against sector-wide shifts in insurance demand and interest-rate conditions. This ongoing repositioning highlights how Allianz is responding to emerging risks such as cyber and AI, potentially reshaping its business mix and long-term operating model. Next, we’ll examine how Allianz’s push into reinsurance and technology partnerships might...

Carl Zeiss Meditec (XTRA:AFX) cut its revenue outlook after a weak start to the year, citing softer sales expectations in the US and China as well as pressure from China’s new volume based procurement process. See our latest analysis for Carl Zeiss Meditec. The revenue guidance cut and first quarter net loss arrived after a sharp reset in sentiment, with a 30 day share price return of 32% decline and a 1 year total shareholder return of 50.65% decline, signalling fading momentum despite...

Deutsche Bank has reached a confidential settlement with former manager Stefano Foresti in a lawsuit tied to the Monte dei Paschi accounting scandal. The agreement concludes the first of several related cases brought by former employees over their alleged involvement in the affair. The outcome may influence how remaining internal disputes linked to the scandal are handled. For you as an investor looking at XTRA:DBK, this legal development comes with the share price at €29.6. The stock has...

Key Insights Friedrich Vorwerk Group's significant public companies ownership suggests that the key decisions are...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

With its stock down 15% over the past three months, it is easy to disregard CTS Eventim KGaA (ETR:EVD). But if you pay...

Future Market Insights projects the global sphingolipids market to reach USD 1,145.6 million by 2035, and Merck KGaA (XTRA:MRK) is identified as a key supplier of high purity sphingolipid products and delivery systems. See our latest analysis for Merck KGaA. Merck KGaA’s role in the sphingolipids market sits against a backdrop of a €127.8 share price, a 10.41% 90 day share price return, and a 5.36% year to date share price return. At the same time, the 1 year total shareholder return of a...

In early February 2026, Nordex SE reported new European onshore wind orders totaling 220 MW across the UK, Turkiye, Lithuania and Sweden, all bundled with multi-year service and maintenance agreements that aim to secure long-term turbine performance in both standard and cold-climate sites. These contracts highlight Nordex’s growing strength in cold-climate and community wind projects, where its anti-icing technology and long-duration service deals are becoming central to how it competes for...

HelloFresh (XTRA:HFG) is back in focus after its share price dropped sharply, following a reported 9% year on year net revenue decline and missed Q4 2025 guidance that rattled investor confidence. See our latest analysis for HelloFresh. The recent Q4 2025 miss and profit warnings have been reflected in the numbers, with a 7 day share price return of 13.86% and a year to date share price return of 11.88%. Over a longer horizon, the 1 year total shareholder return of 58.47% and 5 year total...

In recent days, Deutsche Lufthansa was hit by a 24-hour strike by pilots and cabin crew over pensions and retirement funding, forcing the cancellation of close to 800 flights and disrupting travel for about 100,000 passengers, although the airline aimed to restore a largely normal schedule by the following day. This industrial action underscores persistent labor cost and pension pressures at Lufthansa, raising questions about how reliably the airline can control its core cost base while...

If you are wondering whether PUMA's current share price really reflects the business, you are not alone. This article is built to help you frame that question clearly. PUMA recently closed at €23.45, with returns of 3.3% over 7 days, 5.0% over 30 days and 4.7% year to date, while the 1 year, 3 year and 5 year returns stand at a 19.4% decline, 59.3% decline and 71.6% decline. Recent coverage around PUMA has focused on how the brand is positioned against global sportswear peers and how...

Earnings and contract wins set the tone for investors thyssenkrupp nucera KGaA (XTRA:NCH2) has drawn attention after first quarter earnings showed lower sales and a small net loss, while management reiterated full year guidance and announced a large electrolyzer contract in the Middle East. See our latest analysis for thyssenkrupp nucera KGaA. At a share price of €9.37, the stock has a 1-day share price return of 2.69% and a 90-day share price return of 12.22%. The 1-year total shareholder...

Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been...

SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) defied analyst predictions to release its first-quarter results, which were...

Recent commentary around SAP (XTRA:SAP) has focused on better-than-expected 2025 operating profit, sustained customer demand, and a cluster of cloud and AI partnerships that some investors see as underappreciated by the market. See our latest analysis for SAP. Despite a busy few weeks that included new AI partnerships, a Defense Innovation Hub launch, and fresh collaborations with firms like KPMG and Cohere, SAP’s share price return has been soft. The 30 day share price return shows a decline...

Siemens Healthineers AG has reported past first-quarter 2026 results, with sales of €5,402 million and net income of €449 million, both slightly lower than the prior year. The small step down in revenue and earnings highlights how even modest shifts in quarterly performance can matter for a business built on high-value diagnostic and imaging solutions. We’ll now examine how this modest year-on-year earnings softness influences Siemens Healthineers’ investment narrative built around...

Carl Zeiss Meditec (XTRA:AFX) Q1 2026 Results in Focus Carl Zeiss Meditec (XTRA:AFX) has opened its 2026 financial year with Q1 results that put revenue and EPS front and center, with the latest reported quarter showing €627.5 million in revenue and basic EPS of €0.59, alongside net income of €51.8 million. The company has seen revenue move from €579.6 million and basic EPS of €0.70 in Q4 2024 to €627.5 million and €0.59 in Q4 2025, while trailing 12 month basic EPS sat at €1.61 on €2.23...

Germany’s decision to approve a $129 billion defense budget for 2026, a 45% increase over 2025, immediately draws attention to how this larger procurement pipeline could influence Rheinmetall (XTRA:RHM) and its role in European rearmament. See our latest analysis for Rheinmetall. At a share price of €1,609.0, Rheinmetall’s recent 1 day share price return of 1.87% sits against a 30 day share price return of a 15.27% decline. Its 1 year total shareholder return of 97.94% and very large 5 year...